Right ventricular global strain in patients with hypertrophic cardiomyopathy with and without right ventricular

Yufan Qian1, Xinghan Zhao2, Bing-Hua Chen1

  • 1Department of Radiology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.

PubMed

Insights

Right ventricular global longitudinal strain (RV GLS) and global circumferential strain (RV GCS) predict adverse events in hypertrophic cardiomyopathy (HCM) patients, regardless of RV hypertrophy (RVH). RV GLS is key for RVH patients, while RV GCS is crucial for non-RVH patients.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Cardiac MRI

Background:

  • Hypertrophic cardiomyopathy (HCM) is a genetic heart disease characterized by left ventricular hypertrophy.
  • The prognostic role of right ventricular (RV) function, particularly global strains, in HCM patients remains incompletely understood, especially concerning RV hypertrophy (RVH).

Purpose of the Study:

  • To investigate the prognostic significance of RV global longitudinal strain (GLS) and RV global circumferential strain (GCS) in HCM patients.
  • To determine if these RV strain parameters provide additional predictive value in HCM patients with and without RV hypertrophy (RVH).

Main Methods:

  • A retrospective analysis of 358 HCM patients who underwent cardiac MRI (CMR) and follow-up.
  • RV hypertrophy (RVH) defined as maximal RV wall thickness ≥ 5 mm.
  • RV GLS and RV GCS measured using CMR feature tracking; composite endpoint included mortality, aborted sudden cardiac death (SCD), and heart failure readmission.

Main Results:

  • Over a median follow-up of 25 months, 49 patients reached the composite endpoint.
  • RV GLS was an independent predictor of adverse events in HCM patients with RVH (HR: 1.123, P=0.002).
  • RV GCS was an independent predictor in HCM patients without RVH (HR: 1.174, P=0.015); both improved model discrimination.

Conclusions:

  • RV GLS and RV GCS are independent predictors of adverse outcomes in HCM patients, stratified by RVH status.
  • RV GLS in the RVH group and RV GCS in the non-RVH group offer incremental prognostic value for risk stratification in HCM.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
15
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
15
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
14
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
22